Each Panfor SR-500 sustained – released tablet contains Metformin HCI, BP 500 mg

Metformin hydrochloride is used for the treatment of non-insulin dependent diabetes mellitus (NIDDM) or type 2 DM, particularly in obese and juvenile diabetics in whom diet alone has failed as monotherapy. Metformin could also be used in combination  with insulin or with other oral antidiabetics such as glitazones and sulfonylureas. Glitazone could be used in combination with Metformin when glycemic control is poor during monotherapy and maximum tolerated dose (preferable) of Metformin has been tried. The combination of glitazone plus Metformin is preferred over glitazone plus sulfonylurea especially for obese patients. Metformin could also be used as adjunct to diet and exercise to improve glycemic control in patients with type II diabetes.

Please see the insert.